0001104659-22-123356.txt : 20221130 0001104659-22-123356.hdr.sgml : 20221130 20221130195659 ACCESSION NUMBER: 0001104659-22-123356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221129 FILED AS OF DATE: 20221130 DATE AS OF CHANGE: 20221130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCCANN JOE A. CENTRAL INDEX KEY: 0001868644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39373 FILM NUMBER: 221436831 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: POINT Biopharma Global Inc. CENTRAL INDEX KEY: 0001811764 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850800493 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 BUSINESS PHONE: (317) 543-9957 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 FORMER COMPANY: FORMER CONFORMED NAME: Therapeutics Acquisition Corp. DATE OF NAME CHANGE: 20200511 4 1 tm2231716-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-11-29 0 0001811764 POINT Biopharma Global Inc. PNT 0001868644 MCCANN JOE A. 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 1 1 0 0 Chief Executive Officer Common Stock 2022-11-29 4 P 0 2160 6.64 A 3616313 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.639 to $6.640, inclusive. The Reporting Person undertakes to provide to POINT Biopharma Global Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ William L. Demers, by Power of Attorney for Joe A. McCann 2022-11-30